ClinicalTrials.gov
ClinicalTrials.gov Menu

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01104298
Recruitment Status : Terminated (Interim analysis did not show good results for main objective)
First Posted : April 15, 2010
Last Update Posted : October 27, 2015
Sponsor:
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : May 2014